Q: What is your opinion of ABBV buying an experimental drug derived in the psychedelic space from private company Gilgamesh for 1.2B?. Do you think with some of these psychedelic companies now getting phase 2 and phase 3 trials wrapped up on their potential drug offerings that the psychedelic market might get some legs in the near future as the big pharma companies look for the next big thing. ? With these being very spec who would be you picks in the space for fun money?

Q: Peter

This company, no doubt, is beyond speculative, but would you be able to provide some background/insight. If one were interested in getting into the "psychedelic wellness" trend, would you also suggest any other companies. This is a long term/far-reaching investment, whose concepts are very intriguing to me.

Q: Hello, what are your thoughts of the psilocybin therapeutics sector? Personally, I believe there should be a much better alternative available today to treating mental health issues than our current options. I've read the FDA gave 'Breakthrough Therapy Designation' to COMP360 (by Compass Pathways), and I find this very hopeful. However, as an investment for the next 1-2 years what are you thoughts of this industry and this company (or any company)? Do you see this as just another boom and bust as did the cannabis sector?

Much thx.